Savita Bakhshi Anand

Research Scientist at Evidera

Savita Bakhshi Anand, PhD, has extensive experience in research and academia, currently serving as a Research Scientist at Evidera since June 2014 and as an Associate Editor for Europe's Journal of Psychology since August 2010. Previously held positions include Research Associate and Visiting Research Associate at King's College London, Freelance Writer for jobs.ac.uk, Post-Doctoral Researcher at King's College London, and Health Psychology Specialist at Atlantis Healthcare. Early career roles at London Metropolitan University included Research Fellow, Writing Mentor, Hourly Paid Lecturer, and Research Assistant. Savita Bakhshi Anand holds a BSc (Hons) in Psychology from the University of Reading, an MSc in Health Psychology from University College London and King's College London, and a PhD in Health and Social Psychology from London Metropolitan University.

Location

London, United Kingdom

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Evidera

1 followers

Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.